Applied Molecular Transport Presents Additional Data from Oral AMT-101 Phase 2…
<!-- Name:DistributionId Value:8781004 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Nasdaq:AMTI
Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD…
– Similar clinical remission rates observed in patients receiving AMT-101 monotherapy compared to placebo at week 12 – AMT-101 was well-tolerated – Planned Phase 1b trial for the…
Applied Molecular Transport Announces Publication in Tissue Barriers Providing…
Publication describes critical interactions between cholix-based transport domain and endogenous intracellular trafficking pathways used by Company’s proprietary biologic product candidates…
Applied Molecular Transport Announces Upcoming Investor Events in September and…
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that the…